Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Vulvar Neoplasms 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Polycystic Ovary Syndrome 2Vaginal Atrophy 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Sarcoma, Synovial 1Rectal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Metastatic Breastcancer 1Insulin Resistance 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Endocrine System Diseases 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Atrophic Vaginitis 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

Replens 1Dehydroepiandrosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vaginal Atrophy × Dehydroepiandrosterone × Clear all
NCT04493333 2024-11-27

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

University of Arkansas

Phase 2 Terminated
8 enrolled 11 charts
Breast

Vaginal Atrophy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡